Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Extrinsic gating of the rotary direction of a light-driven molecular motor by dynamic boronic acid–diol complexation

Zi-Jian Chena, Hsiu-Feng Lub, Chun-Wei Chiua, Yi-Hung Liua, Chao-Ping Hsu*bc and Jye-Shane Yang*ad
aDepartment of Chemistry, National Taiwan University, Taipei, 10617, Taiwan. E-mail: jsyang@ntu.edu.tw
bInstitute of Chemistry, Academia Sinica, Taipei, 11529, Taiwan. E-mail: cherri@sinica.edu.tw
cDivision of Physics, National Center for Theoretical Sciences, Taipei, 106319, Taiwan
dCenter for Emerging Material and Advanced Devices, National Taiwan University, Taipei, 10617, Taiwan

Received 5th May 2025 , Accepted 3rd July 2025

First published on 11th July 2025


Abstract

Chiral sterically overcrowded alkenes are potential candidates for artificial light-driven rotary molecular motors (LRMMs), which perform a full 360° unidirectional rotation around the C[double bond, length as m-dash]C bond through a series of photochemical and thermal isomerization processes. However, the majority of the reported LRMMs adopt an intrinsic chirality (i.e., an integration of the chirality center with the photoresponsive unit), which hampers the effective gating of their rotary direction through chirality switching. Herein, we report a new sterically overcrowded alkene equipped with a boronic acid receptor for dynamic covalent bonding with chiral vicinal diols, enabling it to function as an extrinsic chirality-based LRMM. The dynamic boronic acid-chiral diol B–O bonding not only implements the extrinsic chirality to induce a helical preference in the alkene backbone but also facilitates chirality switching through diol exchange to reverse the rotation direction. This work demonstrates that dynamic covalent bonding for extrinsic chirality implementation is an effective strategy for designing direction-switchable LRMMs, paving the way for more sophisticated molecular motors with applications in complex (bio)environments.


Introduction

The precision and efficiency with which nature controls the transmission and directionality of molecular motion to perform work have inspired the development of artificial molecular machines capable of performing designated mechanical functions at the molecular level.1–3 Among these, light-driven rotary molecular motors (LRMMs) undergo light-powered unidirectional 360° rotation, overcoming random thermal motions.4–17 Feringa and co-workers pioneered the use of chiral sterically overcrowded alkenes for designing LRMMs, where unidirectional rotation around the central C[double bond, length as m-dash]C bond leverages the inherent helicity preference arising from the interplay between the chirality center and the alkene backbone.4–10 This 360° unidirectional rotation generally comprises four alternating strokes of light and heat with two energetically uphill photo-E/Z-isomerization (PEZ) steps and two energetically downhill thermal helix inversion (THI) steps. The direction of rotation is determined during the THI steps, in which the metastable helical form produced via PEZ flips its helicity to generate the stable helical form. For instance, in the LRMM illustrated in Fig. 1a, the S-configuration chirality center of the α-carbonyl carbon confers a conformational preference for M helicity, resulting in clockwise rotation. Beyond overcrowded alkenes, LRMMs based on chiral imines,11,12 hemithioindigos13,14 oxindoles,15 and barbituric acids16 have also been developed. Potential applications of LRMMs include controlling the movement of microscale objects on functional surface,18 regulating dynamic supramolecular self-assemblies,19,20 influencing chemical equilibrium,21 opening cell membranes,22–24 facilitating transmembrane ion transport,25 creating artificial muscles,26,27 deforming macroscopic materials,28–30 and governing stem cell differentiation.31
image file: d5sc03240g-f1.tif
Fig. 1 Direction-switchable light-driven rotary molecular motors of sterically overcrowded alkenes: (a and b) the previously reported systems based on intrinsic chirality (IC) (a) and noncovalently bonded extrinsic chirality (EC) (b), and (c) this work based on dynamically covalent bonded extrinsic chirality (EC). The unidirectional rotation is driven by light-powered photo-E/Z-isomerization (PEZ) of the stable isomer to generate the metastable isomer (step 1), followed by thermal helix inversion (THI) to form the stable isomer (step 2). A full 360° rotation is achieved with further consecutive PEZ (step 3) and THI (step 4) for (a) and (c), but only the PEZ for (b). Switching the directionality of LRMMs between clockwise and anticlockwise rotation was performed by base-catalyzed epimerization of the metastable isomer for (a), by using phosphate ligand of opposite chirality for (b), and by transesterification of the boronate ester for (c).

One defining features of biological rotary motors is their ability to switch direction.32,33 However, designing direction-switchable LRMMs remains challenging because it requires effective configuration switching at the chirality center6,9 or altering the rotational axis,34 unlike chemically-powered molecular motors whose directionalities could be switched on demand by flipping the chirality of input reagents.35 To date, only two examples of chirality switching in LRMMs have been reported. The earlier example (Fig. 1a) involves base-catalyzed epimerization of an α-carbonyl chirality center intrinsically integrated into the sterically overcrowded alkene backbone.6 In contrast to this configurational inversion of intrinsic chirality (IC), the second example (Fig. 1b) utilizes the enantiomers of external chirality (EC) for direction switching.9 Specifically, it employs a stiff-stilbene scaffold equipped with thiourea groups, which serve as receptors for noncovalently binding with chiral phosphate ligands in the Z form but not in the E form. The three-step isomerization cycle for a full 360° unidirectional rotation involves the association and dissociation of the chiral ligands, potentially reducing motor efficiency. While the sense of rotation can be altered by using a phosphate ligand of opposite chirality, further experiments to demonstrate direction-switching were not conducted.

Here, we present a new strategy for a direction-switchable LRMM based on dynamic covalent bonding. Specifically, the boronic acid group in a sterically overcrowded alkene (NBO) acts as a receptor for binding with chiral vicinal diols via the well-documented dynamic covalent B–O bonding (Fig. 1c).36–38 Additionally, the presence of an amino group adjacent to the boronic acid enables the formation of an N → B dative bond upon boronic acid–diol complexation.39 Our results demonstrate that the chiral NBO-Diol complexes function as LRMMs and show that chirality exchange via diol substitution leads to a rotary direction switch.

Results and discussion

Molecular design and synthesis

Structural helicity and chirality center-induced helical preference are fundamental features of overcrowded alkene-based LRMMs.4–10 The ortho-substituted stiff-stilbene scaffold in NBO fulfils the requirement for helicity,7,40–42 while the chiral diols (EC) can be readily incorporated by forming cyclic boronate esters with the ortho-aminomethyl phenylboronic group in the rotor unit (the upper half) of NBO. Additionally, the symmetric lower half (the stator unit) of NBO was designed based on the concept of Feringa's second-generation LRMMs to simplify the structural and energetic profile for the rotation cycles.5 We also anticipated that N → B dative bonding would accelerate the esterification process and stabilize the resulting boronic ester,39 thereby facilitating the anchoring of EC. Owing to the dynamic covalent nature of the bonding, direction switching of the resulting NBO-Diol system can be achieved via a thermodynamically controlled exchange of the chiral diol.

Scheme 1 outlines the synthesis of NBO, starting from commercially available 1-indanone though intermediates 1–8. A key step involving the Barton–Kellogg reaction to construct the overcrowded alkene framework of NBO was carried out according to procedures developed by Feringa and coworkers.43 The diol recognition site in NBO was constructed from 6 in three steps: (1) nitrile reduction using DIBAL-H, (2) reductive amination of the resulting formyl group with dimethylamine, and (3) borylation at the bromo-substituted carbon using n-butyl lithium.


image file: d5sc03240g-s1.tif
Scheme 1 Synthesis of NBO.

Diol-induced helical preference

We first employed the C2-symmetric vicinal diol (S,S)-hydrobenzoin (HB) to investigate the helical preference of NBO-Diol complexes (Fig. 2a). This was accomplished by monitoring the spectral evolutions in 1H and 11B NMR (in CD3CN) and circular dichroism (CD, in CH3CN) spectra (Fig. 2b–d). NMR signal assignments were validated using a series of 2D NMR spectra (Fig. S1 and S2). Before diol complexation, the 1H NMR spectrum of NBO exhibits anisochronous resonances (Fig. 2b(i)) for the benzylic protons (H23 and H23′) at 3.5 and 3.9 ppm, indicating a slow THI nature (i.e., racemization). Additionally, the singlet signal for the dimethylamino group (H24 and H24′) at 2.3 ppm reflects rapid rotation about the C–N bond. The 11B NMR spectrum of NBO shows a single resonance at 22.2 ppm (Fig. 2c(i)), consistent with a trigonal geometry at the boron center and the absence of N → B coordination.44 Furthermore, the CD spectrum is silent, confirming the racemic nature of NBO (Fig. 2d). Upon addition of (S,S)-HB, the 11B NMR spectrum exhibits a significant upfield shift from 22.2 ppm to 12.8 ppm, indicating the formation of the boronic acid–diol complex NBO-(S,S)-HB with an N → B dative bond and a tetrahedral geometry at the boron center (Fig. 2c(ii)).44 Formation of the N → B dative bond is further supported by the anisochronous signals for the benzylic protons (H23 and H23′) and the methyl protons (H24 and H24′) (Fig. 2b(ii)). The driving force for N → B bond formation arises from the increased Lewis acidity of the boron atom in the 5-membered cyclic boronate ester.39 Although both P and M helical forms of NBO-(S,S)-HB are initially formed comparable amounts (Fig. 2b(i)–(iii)), heating the solution to 80 °C for four hours results in one form becoming predominant, with a stable: metastable ratio of 95[thin space (1/6-em)]:[thin space (1/6-em)]5, revealing the EC effect of (S,S)-HB on the helical preference of NBO (Fig. 2b(iv)). The difference in Gibbs free energy between the two helical forms induced by the EC effect was determined as 2.0 ± 0.4 kcal mol−1 at 80 °C through van't Hoff analysis (Fig. S3, Tables S1 and S2), which agrees with the observed 95[thin space (1/6-em)]:[thin space (1/6-em)]5 equilibrium ratio. The EC effect also causes different shielding (H9) and deshielding (H6) of the aromatic protons in the metastable and stable forms. Surprisingly, the benzylic protons (H23 and H23′) and methyl protons (H24 and H24′) of the metastable form exhibit a larger downfield shift (Δδ = 0.59 ppm) compared to the stable form (Δδ = 0.53 ppm), indicating stronger N → B bonding in the metastable form. The corresponding CD spectra show a positive Cotton effect for the long-wavelength absorption band (λmax ∼375 nm). For comparison, the enantiomer (R,R)-HB produced mirrored CD spectra (Fig. 2d). Since the chiral diol precursors are CD-silent in this spectral region (Fig. S4), these results clearly demonstrate that chiral diol complexation induces a helical conformational preference in NBO.
image file: d5sc03240g-f2.tif
Fig. 2 (a) Esterification between rac-NBO and (S,S)-hydrobenzoin (HB). The equilibrium constant (Keq) for esterification was determined according to the integration of the 1H NMR signals of the species involved.45 (b)–(d) Spectral evolutions in (b) 1H NMR (400 MHz, CD3CN), (c) 11B NMR (128 MHz, CD3CN), and (d) CD spectra that reflect the HB-induced helical preference of NBO. (e) The crystal structure of rac-NBO, displaying a pair of helical enantiomers assembled by hydrogen bonding (dashed lines). (f) The crystal structure of M-NBO-(S,S)-HB.

The X-ray crystal structures of NBO and NBO-(S,S)-HB provide insights into the stable form present in acetonitrile solution. The crystal of NBO consists of both P and M helical isomers, paired through hydrogen bonding between the trigonal planar boronic acid moieties (Fig. 2e). The O–B–O bond angle is 120.06°, characteristic of trigonal geometry, with an average B–O bond length of 1.36 Å. Additionally, the nitrogen atoms form hydrogen bonds with the boronic hydroxyl groups without establishing an N → B dative bond, consistent with observations in acetonitrile solution. In contrast, the crystal structure of NBO-(S,S)-HB reveals only the M form with an N → B dative bond and a tetrahedral boron center (Fig. 2f). Two independent molecules are present in the crystal, showing slight conformational differences in the overcrowded alkene scaffold. Their N → B dative bond lengths are 1.757 Å and 1.779 Å, while the O–B–O bond angles are 108.31° and 108.75°, with average B–O bond lengths of 1.44 Å and 1.43 Å. Dissolving the crystals in CD3CN produces a 1H NMR spectrum corresponding to the stable form of NBO-(S,S)-HB, confirming that NBO-(S,S)-HB preferentially adopts M helicity in both solution and solid state. Accordingly, M-NBO-(S,S)-HB exhibits a positive CD signal at λmax ∼375 nm, while the opposite CD signal observed for NBO-(R,R)-HB confirms a preference for P helicity.

The correlation between helical preference and the Cotton effect observed for NBO-HB complexes extends to other chiral diols, such as 2,3-butanediol (BD) and diisopropyl tartrate (DIPT). The formation of the NBO-Diol complexes was evidenced by evolution in 1H NMR and CD spectra (Fig. 3) and mass spectrometry (Fig. S5). As shown in Fig. 3a and b, (S,S)-BD induces a positive Cotton effect at 375 nm, indicating a preference for M helicity in NBO-(S,S)-BD (stable: metastable = 70[thin space (1/6-em)]:[thin space (1/6-em)]30, see Fig. S6 for full spectrum). Conversely, the mirrored CD spectrum induced by (R,R)-BD reflects a preference for P helicity. Importantly, even the reduced steric bulkiness of BD compared to HB maintains the helical preference for NBO. Similarly, (R,R)-DIPT, which shares the same absolute configuration as (S,S)-BD and (S,S)-HB, induces M helicity in NBO, with an extent of chirality induction (stable: metastable = 92[thin space (1/6-em)]:[thin space (1/6-em)]8, see Fig. S7 for full spectrum) comparable to that of HB (stable: metastable = 95[thin space (1/6-em)]:[thin space (1/6-em)]5) (Fig. 3c and d). The opposite Cotton effect induced by (S,S)-DIPT further confirms the helicity dependence on the absolute configuration of chiral diols. These findings demonstrate that chiral diols can effectively induce a helical preference upon complexation with NBO. Furthermore, the helicity of NBO-Diol systems is dictated by the absolute configuration of the diols, positioning them as promising candidates for EC-LRMMs.


image file: d5sc03240g-f3.tif
Fig. 3 (a) and (b) The formation of NBO-BD LRMM monitored by (a) 1H NMR (400 MHz, CD3CN) and (b) CD spectra (solvent: CH3CN). (c) and (d) The formation of NBO-DIPT LRMM monitored by (c) 1H NMR (400 MHz, CD3CN) and (d) CD spectra (solvent: CH3CN).

Light-driven unidirectional rotation of NBO-Diol systems

The pure M-NBO-(S,S)-HB LRMM obtained by dissolving the corresponding crystal in acetonitrile serves as an ideal candidate for evaluating the performance of NBO-Diol as an EC-LRMM. Upon irradiation of M-NBO-(S,S)-HB with 419 nm light at ambient temperature, the photostationary state (PSS419nm) exhibits an M-to-P ratio of 25[thin space (1/6-em)]:[thin space (1/6-em)]75, accompanied by inverted CD signals (Fig. 4a). This corresponds to the step-1 rotation (PEZ (1)) shown in Fig. 1c. Subsequent heating of the PSS419nm sample to 80 °C results in a significant recovery of the initial CD signals, indicating the THI from the metastable P form back to the stable M form (i.e., step 2 in Fig. 1c). The M-to-P ratio shifts to 96[thin space (1/6-em)]:[thin space (1/6-em)]4 after this step (denoted as THI80°C). These combined steps of PEZ and THI accomplish a clockwise 180° rotation of rotator about the C[double bond, length as m-dash]C bond. Repeating the same PEZ and THI steps enables a complete 360° unidirectional rotation, thereby establishing the EC-LRMM behavior of NBO-(S,S)-HB.
image file: d5sc03240g-f4.tif
Fig. 4 (a) CD (top) and UV-vis (bottom) spectra (in CH3CN) and (b) 1H NMR spectra (400 MHz, CD3CN) of M-NBO-(S,S)-HB before and after irradiation with 419 nm light at room temperature (PSS419nm), and after heating at 80 °C for 4 hours (THI80°C).

For practical operation, boronic acid-diol complexation should be readily formed and displaced by simple mixing of NBO and chiral diols in solutions without additional purification. In this regard, we evaluated the PEZ and THI behaviors of NBO-(S,S)-HB (M[thin space (1/6-em)]:[thin space (1/6-em)]P = 95[thin space (1/6-em)]:[thin space (1/6-em)]5) generated in situ by mixing rac-NBO with (S,S)-HB, and compared them to those of pure M-NBO-(S,S)-HB samples obtained from single crystals. As shown in Fig. 5a and b, their PEZ and THI behaviors are indistinguishable from those of the pure M-NBO-(S,S)-HB, displaying identical compositions at both PSS419nm (M[thin space (1/6-em)]:[thin space (1/6-em)]P = 25[thin space (1/6-em)]:[thin space (1/6-em)]75) and THI80°C (M[thin space (1/6-em)]:[thin space (1/6-em)]P = 95[thin space (1/6-em)]:[thin space (1/6-em)]5). The evolution in the corresponding CD spectra also mirrored closely to those of M-NBO-(S,S)-HB samples. This trial confirms the in situ generation of NBO-(S,S)-HB complexes is an effective approach to prepare functional NBO-Diol molecular motors.


image file: d5sc03240g-f5.tif
Fig. 5 Spectral changes in 1H NMR (400 MHz, CD3CN) (left) and CD (in CH3CN) (right) spectra of in situ generated LRMMs NBO-(S,S)-HB (a and b), NBO-(S,S)-BD (c and d), and NBO-(S,S)-DIPT (e and f) before (ii) and after irradiation with 419 nm light at room temperature (iii) and after heating at 80 °C (60 °C for NBO-(S,S)-BD) for 4 hours (iv).

Next, we evaluated the unidirectional rotation performance of LRMMs NBO-(S,S)-BD (M[thin space (1/6-em)]:[thin space (1/6-em)]P = 70[thin space (1/6-em)]:[thin space (1/6-em)]30) and NBO-(S,S)-DIPT (M[thin space (1/6-em)]:[thin space (1/6-em)]P = 8[thin space (1/6-em)]:[thin space (1/6-em)]92) prepared in situ in acetonitrile. As shown in Fig. 5c–f, the stable-to-metastable ratios at PSS419nm are 43[thin space (1/6-em)]:[thin space (1/6-em)]57 for NBO-(S,S)-BD and 44[thin space (1/6-em)]:[thin space (1/6-em)]56 for NBO-(S,S)-DIPT. After the THI step, these ratios shift to 70[thin space (1/6-em)]:[thin space (1/6-em)]30 and 92[thin space (1/6-em)]:[thin space (1/6-em)]8, respectively. These results demonstrate that both NBO-Diol systems function as EC-LRMMs, although their directionality, judged by the relative stable-to-metastable ratios, is slightly reduced compared to that of NBO-(S,S)-HB. Interestingly, the rotation of NBO-(S,S)-BD is clockwise, whereas that of NBO-(S,S)-DIPT is anticlockwise (Fig. 1b). This confirms that the rotary direction of NBO-Diol systems can be controlled by the chirality of the diols (BD, DIPT, and HB). Thus, NBO-Diol systems successfully function as EC-LRMMs with a clockwise or anticlockwise rotary motor, depending on the diol chirality. Notably, the THI processes were found faster for NBO-(S,S)-DIPT and NBO-(S,S)-BD, compared to NBO-(S,S)-HB, which contains the bulkiest boronate group in the series (Fig. S8 and Table S3). This suggests that dynamic ligand exchange can not only switch the direction but also fine-tune the rates of the light-driven rotation for NBO-Diol LRMMs.

DFT calculations

To gain deeper structural insights into the THI processes of NBO-(S,S)-HB, DFT calculations were performed at the BMK/6-311+G**//PBE0-D3/6-31G* level of theory using an SMD CH3CN solvation model.46 All calculations were carried out with the Gaussian 09 program (Revision E.01).47 The structure of M-NBO-(S,S)-HB was optimized starting from its crystal structure, and the initial structures of other configurations and THI transition states (TS) were found by rotating the C1–B bond, rather than the C3[double bond, length as m-dash]C4 bond, from the optimized structure of M-NBO-(S,S)-HB. This is because the reorientation of the boronate unit plays a more significant role than the C[double bond, length as m-dash]C torsion during THI, which merely twists the C[double bond, length as m-dash]C bond without breaking it. With this approach, four conformers and two THI TSs are obtained, and the TS with lower energy is reported. A comparison of the crystal structure with the optimized structures is provided in Table S4. Fig. 6a shows the DFT-optimized structures of several representative conformations of NBO-(S,S)-HB, along with corresponding pictorial representations drawn according to the perspective indicated as Fig. 6b. The calculated relative Gibbs free energies of these conformations are also given. The calculations show that the orientation of the N → B dative bond could be parallel or perpendicular to the fluorene stator, referred to as the horizontal form and vertical form, respectively. Interestingly, the observed M-vertical form in crystals is less stable by 1.7 kcal mol−1 in Gibbs free energy at 298 K than the global minimum M-horizontal form. This prediction is consistent with the 2D ROESY spectrum of M-NBO-(S,S)-HB, which shows an NOE correlation between H6 and H24,24′ (Fig. S2(c)), a spatial relationship that is much more likely to exist in the M-horizontal form than in the M-vertical form (Fig. S9). One possible explanation is a larger steric hindrance between (S,S)-HB and the stator in the M-vertical form compared to the M-horizontal form. This is indicated by the distance between the C28 in (S,S)-HB and the stator face (dC28-S), which is shorter in the M-vertical form (dC28-S = 3.366 Å) than in the M-horizontal form (dC28-S = 3.971 Å). Additionally, as indicated by the C1–C2–C3–C4 dihedral angle (θ), the alkene backbone shows a larger twist in the M-vertical form (θ = 43.2°) compared to the M-horizontal form (θ = 38.6°). Another possible explanation for the M-vertical form being less stable than the M-horizontal form is a weaker N → B bond, as indicated by a lower tetrahedral character (THC) for the boron atom in the M-vertical form (THC = 59%) than in the M-horizontal form (THC = 61%).48 The same situation is also found for the P form isomers: the P-horizontal form (dC28-S = 3.343 Å, θ = 41.5°, and THC = 63%) is more stable than the P-vertical form (dC28-S = 3.342 Å, θ = 45.9°, and THC = 60%) by 1.7 kcal mol−1. When compared with the M form with the same N → B orientation (either horizontal or vertical), the P form encounters a larger steric hindrance but possesses a stronger N → B dative bond. The net effect seems determined by the steric effect, as the P form is predicted to be 2.3 kcal mol−1 higher in Gibbs free energy than the M form, consistent with the experimental observations. In the transition state (TS), the N → B dative bond is dissociated, enabling the boronate moiety to pass through the stator. Fig. 6c shows the free energy diagram of the PM THI process. The DFT-derived barrier for the THI process from the P-horizontal form is 27.7 kcal mol−1, which agrees excellently with the experimentally determined 27.0 ± 0.9 kcal mol−1 (Fig. S10, S11 and Tables S5, S6).
image file: d5sc03240g-f6.tif
Fig. 6 (a) The DFT-optimized structures and pictorial representations of five representative conformations of NBO-(S,S)-HB. (b) The structure of M-NBO-(S,S)-HBthat shows the atomic numberings used for discussions. (c) The Gibbs free energy diagram of the PM THI process for NBO-(S,S)-HB, where both the experimental and DFT-calculated values of the energy barrier are shown. The free energies (in kcal mol−1) are referenced against the M form for experimental values and the M-horizontal form for the calculated values.

Upon retrieving the kinetic parameters above, the overall unidirectionality of the full rotation cycle for the NBO-Diol LRMMs warrants discussion. In principle, the unidirectionality of the light-driven rotation of LRMM is governed by the preference for PEZ over its thermal counterpart (TEZ), as well as for THI over the photochemical alternative (PHI). In the photochemical processes of NBO-Diol LRMMs, PEZ should consistently dominate due to its low energy barrier, a characteristic feature of sterically overcrowded stilbenes.49 In contrast, PHI is unfavorable owing to its significantly higher energy barrier. Other potential competing processes, such as photolysis of the boronate moiety, are also unlikely, as they generally require short-wavelength excitation.50,51 Even if such side reactions occur, they would affect only the rotational efficiency without perturbing the overall directionality. Regarding the thermal processes, direct characterization of the TEZ barrier is not feasible for the NBO-Diol LRMMs studied herein, since their C2-symmetric stators preclude clear differentiation between the TEZ and THI pathways. Nevertheless, the TEZ barriers in overcrowded stilbenes rarely fall below 28.8 kcal mol−1,52 which remains higher than the THI barrier determined for M-NBO-(S,S)-HB (27.7 kcal mol−1), which is the highest among the NBO-Diol series. A recent example of an overcrowded stilbene with a lower TEZ barrier involves the incorporation of push–pull substituents para to the olefin bond, which reduces its bond order via enhanced charge-transfer character.53 In the absence of such structural modifications, the TEZ barriers for the NBO-Diol LRMMs studied here should remain sufficiently higher than their THI barriers, rendering the impact of the TEZ pathway on overall rotational unidirectionality negligible. Therefore, it is reasonable to conclude that the NBO-Diol LRMMs exhibit net unidirectionality in their light-driven rotations, as the designated directionality is preserved across both the photochemical and thermal pathways that make up the full rotation cycle.

In addition, the role of the N → B dative bond in NBO was also investigated. We first optimized the crystal structure of M-NBO, which features intramolecular O–H⋯N hydrogen bonds, yielding a hydrogen-bonded conformer (NBOHB, Fig. S12(a)). Moreover, an N → B coordinated conformer (NBON→B, Fig. S12(b)) was derived from the optimized structure of M-NBO-(S,S)-HB by removing the HB moiety, followed by geometric re-optimization. The NBOHB conformer was found to be slightly more stable than NBON→B by 0.4 kcal mol−1. We also evaluated interconversion between these two conformers by calculating the corresponding transition state (NBOTS, Fig. S12(c)), which predicted a small energy barrier of 7.65 kcal mol−1. This suggests that both conformers coexist in equilibrium at room temperature, with an approximate NBON→B to NBOHB ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]2. In other words, only one-third of NBO molecules exhibit N → B coordination at room temperature, indicating a relatively weak N → B bond in NBON→B. This conclusion is supported by the longer N → B bond length (1.774 Å vs. 1.686 Å) and lower THC (44% vs. 61%) at the boron center in NBON→B compared to M-NBO-(S,S)-HB. The observed upfield shift in the 11B NMR signal upon formation of M-NBO-(S,S)-HB from NBO is also consistent with this analysis.

Direction-switching experiments of NBO-Diol motors

One of the strategies for switching the rotary direction of NBO-Diol motors is competitive diol exchange: namely, using diols with opposite helical preference for exchange (Fig. 7a). For example, diols with a high affinity for forming the boronate ester can displace the weakly bound diols (e.g., (S,S)-HB vs. (S,S)-DIPT). In the case of two diols with similar binding affinities (e.g., (S,S)-BD and (S,S)-DIPT), the one present at relatively high concentration would dominate the boronate ester formation. To demonstrate this strategy, we conducted an experiment involving sequential addition of chiral diols (S,S)-BD, (S,S)-DIPT, and (S,S)-HB into a solution of NBO, and monitored the process by 1H NMR (Fig. 7b) and CD (Fig. 7c) spectroscopies. Similar to aforementioned experiments, the samples were heated after the addition of chiral diols to facilitate equilibration. The formation of the clockwise rotary motor NBO-(S,S)-BD was confirmed by the downfield and upfield shifts of the aromatic protons H6 and H9, respectively (Fig. 7b(i)). Then, 4.0 equivalents of (S,S)-DIPT were added to replace (S,S)-BD and generate the anticlockwise motor NBO-(S,S)-DIPT, accomplishing the first directionality switch (Fig. 7b(ii)). The second directionality switch followed by adding 3.0 equivalents of (S,S)-HB to replace (S,S)-DIPT, which led to the formation of the clockwise rotary motor NBO-(S,S)-HB (Fig. 7b(iii)). Note that the motor function of NBO-(S,S)-HB is not affected in the presence of free diols of opposite stereochemical configuration, such as (S,S)-DIPT. This is evidenced by an independent set of light-driven rotation experiment, in which the sample was prepared by adding 3.0 equivalents of (S,S)-HB into the CD3CN solution of NBO-(S,S)-DIPT (Fig. S13). These results demonstrate the feasibility of direction switching in EC-LRMMs such as the NBO-Diol systems.
image file: d5sc03240g-f7.tif
Fig. 7 Two strategies for directional switching of the NBO-Diol LRMMs. (a)–(c) The competitive ligand exchange strategy: conceptual representation (a), and spectral evolutions in 1H NMR (400 MHz, CD3CN) (b) and CD spectra (in acetonitrile) of (i) NBO upon successive addition of (ii) (S,S)-BD (clockwise rotation), (iii) (S,S)-DIPT (anticlockwise rotation), and (iv) (S,S)-HB (clockwise rotation). (d)–(f) The NBO resetting strategy: conceptual representation (d), and spectral evolutions in 1H NMR (400 MHz, CD3CN/D2O = 9/1) (e), and CD spectra (in acetonitrile) (f) of (i) NBO upon successive treatment of (ii) (S,S)-HB addition (clockwise rotation), (iii) resetting with PBA, (iv) (R,R)-HB addition (anticlockwise rotation), and (v) a repeat of step (iii) that recovers NBO. Procedure for PBA resetting: PBA (5.0 eq), HCl(aq) (1.5 eq) overnight, followed by filtration to remove the solids, and then adding NaOH(aq) (1.5 eq).

Another strategy for switching the rotary direction in NBO-Diol motors is the recovery of the free receptor NBO, a resetting process, by removing the bound diol with a competing reagent (Fig. 7d). Once NBO is recovered, new chiral diols with different helical preference can be added to regenerate NBO-Diol motors with the opposite rotary direction. Solid-phase polystyrene-boronic acid (PBA) has been used for removing pinacol from pinacolyl boronate esters in acetonitrile solutions through transesterification and filtration.54 The ability of PBA to extract the chiral diols from NBO-Diol motors and thus reset NBO has been demonstrated by the reaction of NBO-(S,S)-HB with 1.5 equivalents of HCl and 5.0 equivalents of PBA in 9[thin space (1/6-em)]:[thin space (1/6-em)]1 CD3CN/D2O. Since the amino group is protonated under acid conditions, the N →B dative bonding no longer exists, facilitating the removal of (S,S)-HB by PBA. Neutralization of the solution with 1.5 equivalents of NaOH is required to recover NBO. Following this resetting process, direction-switching can be achieved by adding one equivalent of (R,R)-HB to the solution. This results in the formation of the anticlockwise rotary motor NBO-(R,R)-HB, as confirmed by the appearance of a new set of signals in the NMR spectrum (Fig. 7e) and the mirrored CD spectrum (Fig. 7f).

Conclusions

We have demonstrated the first example of dynamic covalent bonding-based LRMMs: the NBO-Diol systems. In these systems, the full 360° unidirectional rotation about the C[double bond, length as m-dash]C bond can be switched from clockwise to anticlockwise, or vice versa, by altering the vicinal diol chirality through competitive diol exchange or NBO resetting methods. Similar to LRMMs based on intrinsic chirality, the rotation of NBO-Diol systems involves alternating photoisomerization and thermal helix inversion without requiring the dissociation of the external chiral diol. This work highlights dynamic covalent bonding as a powerful strategy for tuning the performance of artificial molecular machinery, offering enhanced precision and efficiency for targeted tasks.

Data availability

All experimental procedures and characterization data are available in the ESI. CCDC 2294943 (NBO) and 2294942 (M-NBO-(S,S)-HB) contain supplementary crystallographic data for this paper.

Author contributions

J.-S. Y. conceived the project. Z.-J. C. carried out the experiments. H.-F. L. and C.-P. H. performed theoretical calculations. Y.-H. L. did the crystallographic analysis. Z.-J. C., C.-W. C. and J.-S. Y. wrote, edited and completed the manuscript.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgements

Financial support for this research was provided by the National Science and Technology Council of Taiwan (NSTC 110-2113-M-002-011-MY3; 113-2123-M-002-013) and National Taiwan University (NTU-113L892002). CPH acknowledgements support from Academia Sinica (AS-IV-114-M01), Academia Sinica Grid Computing Centre, (AS-CFII-114-A11), and National Science and Technology Council of Taiwan (NSTC 114-2811-M-001-015). We thank Dr Hsi-Ching Tseng at the NTU Instrumentation Center for the assistance in NMR experiments, and NTU Consortia of Key Technologies for the mass spectrometry technical research services.

References

  1. Y. Feng, M. Ovalle, J. S. W. Seale, C. K. Lee, D. J. Kim, R. D. Astumian and J. F. Stoddart, J. Am. Chem. Soc., 2021, 143, 5569–5591 CrossRef CAS PubMed.
  2. V. García-López, D. Liu and J. M. Tour, Chem. Rev., 2020, 120, 79–124 CrossRef PubMed.
  3. M. Baroncini, S. Silvi and A. Credi, Chem. Rev., 2020, 120, 200–268 CrossRef CAS PubMed.
  4. N. Koumura, R. W. J. Zijlstra, R. A. van Delden, N. Harada and B. L. Feringa, Nature, 1999, 401, 152–155 CrossRef CAS PubMed.
  5. N. Koumura, E. M. Geertsema, A. Meetsma and B. L. Feringa, J. Am. Chem. Soc., 2000, 122, 12005–12006 CrossRef CAS.
  6. N. Ruangsupapichat, M. M. Pollard, S. R. Harutyunyan and B. L. Feringa, Nat. Chem., 2011, 3, 53–60 CrossRef CAS PubMed.
  7. P. Štacko, J. C. M. Kistemaker, T. van Leeuwen, M.-C. Chang, E. Otten and B. L. Feringa, Science, 2017, 356, 964–968 CrossRef PubMed.
  8. D. Roke, S. J. Wezenberg and B. L. Feringa, Proc. Natl. Acad. Sci. U. S. A., 2018, 115, 9423–9431 CrossRef CAS PubMed.
  9. S. J. Wezenberg and B. L. Feringa, Nat. Commun., 2018, 9, 1984 CrossRef PubMed.
  10. J. C. M. Kistemaker, P. Štacko, J. Visser and B. L. Feringa, Nat. Chem., 2015, 7, 890–896 CrossRef CAS PubMed.
  11. L. Greb and J.-M. Lehn, J. Am. Chem. Soc., 2014, 136, 13114–13117 CrossRef CAS PubMed.
  12. L. Greb, A. Eichhöfer and J.-M. Lehn, Angew. Chem., Int. Ed., 2015, 54, 14345–14348 CrossRef CAS PubMed.
  13. M. Guentner, M. Schildhauer, S. Thumser, P. Mayer, D. Stephenson, P. J. Mayer and H. Dube, Nat. Commun., 2015, 6, 8406 CrossRef CAS PubMed.
  14. L. A. Huber, K. Hoffmann, S. Thumser, N. Böcher, P. Mayer and H. Dube, Angew. Chem., Int. Ed., 2017, 56, 14536–14539 CrossRef CAS PubMed.
  15. D. Roke, M. Sen, W. Danowski, S. J. Wezenberg and B. L. Feringa, J. Am. Chem. Soc., 2019, 141, 7622–7627 CrossRef CAS PubMed.
  16. K. Kuntze, D. R. S. Pooler, M. Di Donato, M. F. Hilbers, P. van der Meulen, W. J. Buma, A. Priimagi, B. L. Feringa and S. Crespi, Chem. Sci., 2023, 14, 8458–8465 RSC.
  17. D. R. S. Pooler, A. S. Lubbe, S. Crespi and B. L. Feringa, Chem. Sci., 2021, 12, 14964–14986 RSC.
  18. R. Eelkema, M. M. Pollard, J. Vicario, N. Katsonis, B. S. Ramon, C. W. M. Bastiaansen, D. J. Broer and B. L. Feringa, Nature, 2006, 440, 163 CrossRef CAS PubMed.
  19. D. Daou, Y. Zarate, M. Maaloum, D. Collin, G. Fleith, D. Constantin, E. Moulin and N. Giuseppone, Adv. Mater., 2024, 36, 2311293 CrossRef CAS PubMed.
  20. Y. Qutbuddin, A. Guinart, S. Gavrilović, K. Al Nahas, B. L. Feringa and P. Schwille, Adv. Mater., 2024, 36, 2311176 CrossRef CAS PubMed.
  21. M. Kathan, S. Crespi, N. O. Thiel, D. L. Stares, D. Morsa, J. de Boer, G. Pacella, T. van den Enk, P. Kobauri, G. Portale, C. A. Schalley and B. L. Feringa, Nat. Nanotechnol., 2022, 17, 159–165 CrossRef CAS PubMed.
  22. V. García-López, F. Chen, L. G. Nilewski, G. Duret, A. Aliyan, A. B. Kolomeisky, J. T. Robinson, G. Wang, R. Pal and J. M. Tour, Nature, 2017, 548, 567–572 CrossRef PubMed.
  23. A. Guinart, M. Korpidou, D. Doellerer, G. Pacella, M. C. A. Stuart, I. A. Dinu, G. Portale, C. Palivan and B. L. Feringa, Proc. Natl. Acad. Sci. U. S. A., 2023, 120, e2301279120 CrossRef CAS PubMed.
  24. B. B. Berking, S. J. Rijpkema, B. H. E. Zhang, A. Sait, H. Amatdjais-Groenen and D. A. Wilson, ACS Biomater. Sci. Eng., 2024, 10, 5881–5891 CrossRef CAS PubMed.
  25. S. Deng, Z. Li, L. Yuan, J. Shen and H. Zeng, Nano Lett., 2024, 24, 10750–10758 CrossRef CAS PubMed.
  26. J. Chen, F. K.-C. Leung, M. C. A. Stuart, T. Kajitani, T. Fukushima, E. van der Giessen and B. L. Feringa, Nat. Chem., 2018, 10, 132–138 CrossRef CAS PubMed.
  27. X. Yao, J. A. Vishnu, C. Lupfer, D. Hoenders, O. Skarsetz, W. Chen, D. Dattler, A. Perrot, W.-z. Wang, C. Gao, N. Giuseppone, F. Schmid and A. Walther, Adv. Mater., 2024, 36, 2403514 CrossRef CAS PubMed.
  28. A. Perrot, W.-z. Wang, E. Buhler, E. Moulin and N. Giuseppone, Angew. Chem., Int. Ed., 2023, 62, e202300263 CrossRef CAS PubMed.
  29. Q. Li, G. Fuks, E. Moulin, M. Maaloum, M. Rawiso, I. Kulic, J. T. Foy and N. Giuseppone, Nat. Nanotechnol., 2015, 10, 161–165 CrossRef CAS PubMed.
  30. A. Ryabchun, F. Lancia, J. Chen, R. Plamont, D. Morozov, B. L. Feringa and N. Katsonis, Chem, 2023, 9, 3544–3554 CAS.
  31. Q. Zhou, J. Chen, Y. Luan, P. A. Vainikka, S. Thallmair, S. J. Marrink, B. L. Feringa and P. van Rijn, Sci. Adv., 2020, 6, eaay2756 CrossRef CAS PubMed.
  32. D. J. DeRosier, Cell, 1998, 93, 17–20 CrossRef CAS PubMed.
  33. K. Kinosita, R. Yasuda, H. Noji, S. i. Ishiwata and M. Yoshida, Cell, 1998, 93, 21–24 CrossRef CAS PubMed.
  34. L. Reißenweber, E. Uhl, F. Hampel, P. Mayer and H. Dube, J. Am. Chem. Soc., 2024, 146, 23387–23397 CrossRef PubMed.
  35. S. Borsley, E. Kreidt, D. A. Leigh and B. M. W. Roberts, Nature, 2022, 604, 80–85 CrossRef CAS PubMed.
  36. S. Chatterjee, E. V. Anslyn and A. Bandyopadhyay, Chem. Sci., 2021, 12, 1585–1599 RSC.
  37. Y. Kubo, R. Nishiyabu and T. D. James, Chem. Commun., 2015, 51, 2005–2020 RSC.
  38. S. D. Bull, M. G. Davidson, J. M. H. van den Elsen, J. S. Fossey, A. T. A. Jenkins, Y.-B. Jiang, Y. Kubo, F. Marken, K. Sakurai, J. Zhao and T. D. James, Acc. Chem. Res., 2013, 46, 312–326 CrossRef CAS PubMed.
  39. X. Sun, B. M. Chapin, P. Metola, B. Collins, B. Wang, T. D. James and E. V. Anslyn, Nat. Chem., 2019, 11, 768–778 CrossRef CAS PubMed.
  40. Z.-J. Chen, H.-F. Lu, I. Chao and J.-S. Yang, J. Org. Chem., 2022, 87, 5029–5034 CrossRef CAS PubMed.
  41. Z.-J. Chen, H.-F. Lu, I. Chao and J.-S. Yang, J. Chin. Chem. Soc., 2022, 69, 1475–1484 CrossRef CAS.
  42. Z.-J. Chen, H.-F. Lu, C.-W. Chiu, F.-M. Hou, Y. Matsunaga, I. Chao and J.-S. Yang, Org. Lett., 2020, 22, 9158–9162 CrossRef CAS PubMed.
  43. S. F. Pizzolato, P. Štacko, J. C. M. Kistemaker, T. van Leeuwen, E. Otten and B. L. Feringa, J. Am. Chem. Soc., 2018, 140, 17278–17289 CrossRef CAS PubMed.
  44. S. A. Valenzuela, J. R. Howard, H. M. Park, S. Darbha and E. V. Anslyn, J. Org. Chem., 2022, 87, 15071–15076 CrossRef CAS PubMed.
  45. R. A. Brown, V. Diemer, S. J. Webb and J. Clayden, Nat. Chem., 2013, 5, 853–860 CrossRef CAS PubMed.
  46. A. V. Marenich, C. J. Cramer and D. G. Truhlar, J. Phys. Chem. B, 2009, 113, 6378–6396 CrossRef CAS PubMed.
  47. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery Jr, J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, Gaussian 09, 2009 Search PubMed.
  48. H. Höpfl, J. Organomet. Chem., 1999, 581, 129–149 CrossRef.
  49. M. Quick, F. Berndt, A. L. Dobryakov, I. N. Ioffe, A. A. Granovsky, C. Knie, R. Mahrwald, D. Lenoir, N. P. Ernsting and S. A. Kovalenko, J. Phys. Chem. B, 2014, 118, 1389–1402 CrossRef CAS PubMed.
  50. R. F. Porter and L. J. Turbini, Photochemistry of Boron Compounds, Springer, Berlin, 1981 Search PubMed.
  51. A. Pelter, R. T. Pardasani and P. Pardasani, Tetrahedron, 2000, 56, 7339–7369 CrossRef CAS.
  52. J. C. M. Kistemaker, S. F. Pizzolato, T. van Leeuwen, T. C. Pijper and B. L. Feringa, Chem. Eur. J., 2016, 22, 13478–13487 CrossRef CAS PubMed.
  53. L. Pfeifer, S. Crespi, P. van der Meulen, J. Kemmink, R. M. Scheek, M. F. Hilbers, W. J. Buma and B. L. Feringa, Nat. Commun., 2022, 13, 2124 CrossRef CAS PubMed.
  54. T. E. Pennington, C. Kardiman and C. A. Hutton, Tetrahedron Lett., 2004, 45, 6657–6660 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. CCDC 2294942 and 2294943. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d5sc03240g

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.